Session Details
Oral Presentation（Lung） 9 English Session 2
Fri. Oct 24, 2025 10:50 AM - 11:50 AM JST
Fri. Oct 24, 2025 1:50 AM - 2:50 AM UTC
Fri. Oct 24, 2025 1:50 AM - 2:50 AM UTC
Grande Toque, 12 fl, Osaka International Convention Center
座長：朝倉 啓介(慶應義塾大学医学部 外科学（呼吸器）), 鈴木 あゆみ(がん研究会有明病院)
English Session
[LOP9-2]Neoadjuvant Checkpoint Inhibitors：Does different ICI drugs Matter?
Xing Jin (Department of Thoracic Surgery, Zhongshan Hospital, Fudan University)
[LOP9-3]Screening of Programmed Cell Death-Related Genes and Exploration of Their Mechanisms in Lung squamous cell carcinoma
Simiao Lu1,2 (1.Department of Thoracic Surgery, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital ＆ Institute, Sichuan Cancer Center, Affiliated Cancer Hospital of University of Electronic Science and Technology of China（Sichuan Cancer Hospital）, 2.Chongqing Medical University, Chongqing, China)
[LOP9-5]Targeting SAT1-mediated polyamine metabolism and ferroptosis to enhance the efficacy of targeted therapy in KRAS-mutant cancer with differential KEAP1 status
Yunyi Bian (Shanghai Chest Hospital, Shanghai, China)
[LOP9-6]UXS1 Targeting Synergizes with Metformin in Lung Adenocarcinoma
Qihai Sui (Department of Thoracic Surgery, Zhongshan Hospital Fudan University)
[LOP9-7]Metformin Enhances Neoadjuvant Chemotherapy and Immunotherapy Efficacy in Non-Small Cell Lung Cancer by Promoting Ferroptosis in M2 Macrophages through the AMPK/KLF4/TFRC Pathway
Han Lin (Department of Thoracic Surgery, Zhongshan Hospital, Fudan University, Shanghai, China)